Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 1081-1083

  Pati, A R ^a,b   Godder, K T ^a   Abhyankar, S H ^a   Gee, A P ^a   Henslee Downey, P J ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Division of Transplantation Medicine   (United States)

Author keywords

Autologous GVHD; Cyclosporine; Lymphoma

Indexed keywords

CARMUSTINE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; HYDROCORTISONE; MELPHALAN; STEROID;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOTRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONDITIONING; DRUG EFFICACY; FEMALE; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ADULT; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030018930     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
2. Jiang YZ, Kanfer EJ, MacDonald D et al. Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T-lymphocytes reacting to host leukaemia cells. Bone Marrow Transplant 1991; 8: 253-258.
3. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T cell depletion. Ann Intern Med 1988; 108: 806-814.
4. Kersey JH, Weisdorf D, Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. New Engl J Med 1987; 317; 461-467.
5. Jones RJ, Vogelsang GB, Ambinder RF et al. Autologous marrow transplant with cyclosporine induced autologous graft-versus-host disease for relapsed aggressive non-Hodgkin's lymphoma. Blood 1991; 78: 287a (Abstr. 1137).
6. Jones RJ, Vogelsang GB, Hess AD et al. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989; 1: 754-756.
7. Talbot DC, Powles RL, Sloan JP et al. Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia. Bone Marrow Transplant 1990; 6: 17-20.
8. Carella AM, Gaozza E, Congiu A et al. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies. Ann Hematol 1991; 62: 156-159.
9. Rizzoli V, Carella AM, Carlo-Stella C, Mangoni L. Autologous marrow transplantation in acute lymphoblastic leukemia: control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group. Bone Marrow Transplant 1990; 6 (Suppl. 1): 76-78.
10. Yeager AM, Vogelsang GB, Jones RJ et al. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia. Leuk Lymphoma 1993; 11: 215-220.
11. Kennedy MJ, Vogelsang GB, Beveridge RA et al. Phase I trial of intravenous cyclosporine A to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1993; 11: 478-484.
12. Ratanatharathorn V, Uberti J, Karanes C et al. Phase I study of alpha-interferon augmentation of cyclosporine-induced graft-versus-host disease in recipients of autologous bone marrow transplantation. Bone Marrow Transplant 1994; 13: 625-630.
13. Hess AD, Horwitz LR, Laulis MK et al. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo. Transplant Proc 1993; 25: 1218-1221.
14. Glazier A, Tutschka PJ, Farmer ER, Santos GW. Graft-versus-host disease in cyclosporin A treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1993; 158: 1-8.
15. Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061-2067.
16. Geller R, Esa A, Beschorner W et al. Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine induced syngeneic graft-versus-host disease in the rat. Blood 1989; 74: 1165-1171.
17. Vose MJ, Anderson JR, Kessinger A et al. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1846-1851.